{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P07858",
      "entity_text" : "cathepsin B",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00309",
      "entity_text" : "CA-074",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The irreversible cathepsin B inhibitor CA-074 was developed from the broad-spectrum cathepsin inhibitor E-64 XREF_BIBR and highly selectively inhibits intracellular cathepsin B in vitro XREF_BIBR.",
  "reading_complete" : "2020-08-02T10:51:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:49:53Z",
  "trigger" : "inhibits",
  "evidence" : [ "CA-074 was developed from the broad-spectrum cathepsin inhibitor E-64  XREF_BIBR  and highly selectively inhibits intracellular cathepsin B" ],
  "pmc_id" : "6587341",
  "score" : 0
}